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ABSTRACT: Stereotactic lesioning of the bilateral
globus pallidus (GPi) was one of the first surgical treat-
ments for medication-refractory dystonia but has largely
been abandoned in clinical practice after the introduction
of deep brain stimulation (DBS). However, some patients
with dystonia are not eligible for DBS. Therefore, we
reviewed the efficacy, safety, and sustainability of bilat-
eral pallidotomy by conducting a systematic review of
individual patient data (IPD). Guidelines of the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses and IPD were followed. In May 2020, Medline,
Embase, Web of Science, and Cochrane Library were
searched for studies reporting on outcome of bilateral
pallidotomy for dystonia. If available, IPD were collected.
In this systematic review, 100 patients from 33 articles
were evaluated. Adverse events were reported in
20 patients (20%), of which 8 were permanent (8%). Pre-
and postoperative Burke-Fahn-Marsden Dystonia Rating
Movement Scale scores were available for 53 patients. A
clinically relevant improvement (>20%) of this score was
found in 42 of 53 patients (79%). Twenty-five patients
with status dystonicus (SD) were described. In all but
2 the SD resolved after bilateral pallidotomy. Seven
patients experienced a relapse of SD. Median-reported
follow-up was 12 months (n = 83; range: 2–180 months).
Based on the current literature, bilateral pallidotomy is an
effective and relatively safe procedure for certain types
of dystonia, particularly in medication-refractory SD.
Although due to publication bias the underreporting of
negative outcomes is very likely, bilateral pallidotomy is a
reasonable alternative to DBS in selected dystonia
patients. © 2020 The Authors. Movement Disorders pub-
lished by Wiley Periodicals LLC on behalf of International
Parkinson and Movement Disorder Society.
Key Words: pallidotomy; dystonia; safety; efficacy;
sustainability
Dystonia is a movement disorder characterized by
sustained or intermittent muscle contractions, causing
abnormal, often repetitive movements, postures, or
both.1 It is a debilitating disorder with a high burden of
disease.2 If pharmacological treatment fails, stereotactic
functional neurosurgery is an established next step in the
treatment algorithm. It is considered the most successful
strategy in life-threatening, medication-refractory status
dystonicus (SD).3
Nowadays, deep brain stimulation (DBS) is preferred
over lesioning techniques for dystonia.4-7 However, from
the 1950s to the 1980s, thalamotomy and pallidotomy
were the cornerstones of stereotactic neurosurgical treat-
ment for dystonia.8,9 Although DBS of the pallidum has
important advantages over ablative procedures, including
its reversibility and the ability to adjust stimulation
parameters, it also has its limitations. Adverse events such
as infection, skin erosion, and hardware malfunction, but
also lifelong follow-up and neurological side effects, for
example, long-term akinesia and gait disorder, are well
known. In fact, hardware-related issues are more common
in patients with dystonia than in patients with other
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movement disorders.10 Furthermore, DBS is expensive,
and reimbursement and availability vary among
countries.11
Cognitive impairment, young age, cachectic state,
and inability to comply with follow-up visits are recog-
nized as valid reasons to refrain from DBS.12 Severe
medical-refractory dystonia and SD often coincide with
impaired cognition and cachectic state, particularly in
the case of neurometabolic or neurodegenerative dis-
eases. In these patients bilateral pallidotomy is a valid
treatment, but this step is not easily taken. The litera-
ture on this topic is limited to case reports and case
series. Therefore, we performed this systematic review
and collected the individual patient data (IPD) to assess
the efficacy, safety, and sustainability of bilateral
pallidotomy in patients with dystonia.
Patients and Methods
A systematic review was conducted according to the
guidelines of the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA, Fig. 1).13 A
systematic search for relevant studies was performed up
to May 2020, based on electronic databases Cochrane
Library, Medline, Embase, and Web of Science. The
search strategy was designed using the Medical Subject
Headings terms “pallidotomy” and “dystonia.” The
references of the included articles were scrutinized for
other relevant studies.
Study Selection
Three authors independently made the study selec-
tion. Disagreements were solved in a consensus meet-
ing. Peer-reviewed full-text papers that reported on
motor outcome were selected. The initial selection was
based on screening of titles and abstracts. Further selec-
tion was made after reading and cross-reading of the
full text. Patients with dystonia in the context of
Parkinson’s disease were excluded. Studies with over-
lapping patients were also excluded, except when addi-
tional IPD could be obtained by including both articles.
In case of missing data, an attempt to contact the
corresponding author was made twice by e-mail.
Data Extraction
The following data were extracted: (1) Patient char-
acteristics: age, gender, diagnosis, and dystonia type;
(2) efficacy of pallidotomy, as expressed by an improve-
ment in motor performance (Burke-Fahn-Marsden Dys-
tonia Rating Scale [BFMDRS],14 Unified Dystonia
Rating Scale [UDRS], or any other qualitative or quan-
titative description); (3) safety in terms of reported
FIG. 1. Improvement Burke-Fahn-Marsden Dystonia Rating Scale movement score at the end of reported follow-up (n = 53). [Color figure can be
viewed at wileyonlinelibrary.com]
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adverse events, which were categorized as transient or
permanent; and (4) sustainability of the lesion effect
and duration of follow-up. Ten corresponding authors
were contacted to retrieve supplementary IPD. Four
authors responded, which led to additional IPD of one
patient.15
Methodological Quality Assessment
Methodological quality of case series was assessed
using the tool of Moga et al.16 Case reports were
assessed using an adapted version of the same tool
(Table APPENDIX S1). To assess the methodological
quality of the included case series and case reports, the
overall percentage of agreement was calculated. Subse-
quently, two separate Cohen’s kappas were calculated
for both the case reports and the case series assessment
to assess interrater agreement.
Data Analysis
Data were analyzed using SPSS version 22. Descrip-
tive statistics were used for analysis of IPD. To describe
age and duration of follow-up, means and standard
deviations were used. For categorical variables (gender,
type of dystonia, diagnosis, UDRS, and side effects),
frequencies with percentages were used. The BFMDRS
movement score was assessed separately, if available.
For this score, the relative change percentage was sub-
divided into four categories: >40%, 20–40%, <20%,
and worsening (relative to baseline).
Results
Study Selection
The electronic search yielded 1149 papers (Medline:
296, Embase: 452, Web of Science: 401, and Cochrane
Library: 0). No randomized clinical trials were found.
After duplicates were removed, 764 papers remained.
Titles and abstracts were screened for eligibility. Subse-
quently, 166 full-text papers were read and assessed for
eligibility. Initially non-English articles were excluded.
However, due to scarcity of literature, non-English
papers were also assessed. Finally, 33 papers met our
inclusion criteria and were included in this
review.15,17-48 The reasons to exclude the other 133 arti-
cles were the following: congress abstracts (n = 37),
described no patients (n = 25), full text not available
(n = 18), unilateral pallidotomy (n = 15), Parkinson’s
disease (n = 12), no (motor) outcomes (n = 9), patients
described before (n = 7), thalamotomy or other lesions
(n = 6), no dystonia patients (n = 2), and DBS only
(n = 2) ( FIGURE S1).
Patient and Study Characteristics
The 33 included studies were published between
1996 and 2020, describing 100 patients (Table 1). If
sufficient data were available, IPD were collected
(Table 2). The included studies were case series
(n = 14), case reports (n = 18), and a letter to the editor
(n = 1). The number of enrolled patients per study var-
ied from 1 to 18. The majority of patients suffered from
generalized dystonia before surgery (65%); 25 patients
(25%) had SD. Seven patients (7%) had focal or other
forms of dystonia. Thirty-one patients (31%) had a
confirmed genetic diagnosis, 18 of whom had DYT1
dystonia, caused by a mutation in the TOR1A gene.
Table 1 presents additional information on etiology
and clinical presentation. The median age at surgery
was 17 years (n = 85).
Methodological Quality Assessment
The overall agreement between raters was 91%
(190/209) for case reports and 86% (216/252) for case
series. Both Cohen’s kappas were substantial (case
reports: 0.76, case series: 0.67). Therefore, the inter-
rater variability is low (APPENDIX S1).
TABLE 2. Individual patient data group characteristics
Characteristic Total population




Mean age at surgery ± SD (y), n = 70 20 ± 13.9
Type of dystonia (n = 72)
Generalized 49/72 (68%)
Status dystonicus 16/72 (22%)
Focal 6/72 (8%)
Camptocormia 1/72 (1%)
Mean duration of follow-up ± SD (mo), n = 67 19.7 ± 27.7









UDRS (n = 17)
Improvement ≥20% 11/17 (65%)
Score decrease <20% 4/17 (24%)
No change or worsening 2/17 (12%)
Side effects (n = 75)
Transient 6/75 (8%)
Permanent 8/75 (11%)
Abbreviations: BFMDRS, Burke-Fahn-Marsden Dystonia Rating Scale;
UDRS, Unified Dystonia Rating Scale.
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Efficacy
Of 100 patients, BFMDRS scores were assessed for
53 patients pre- and postoperatively. One paper presented
improvement percentage for 18 patients on a group level
instead of individual scores.34 The outcome for patients
lacking a BFMDRS score was quantified by the UDRS
(n = 17), a qualitative description of motor results
(n = 12), or another scale (n = 3). Of note, a variety of
other scales were used, and some patients were scored
twice on separate scoring systems: Barry Albright Dysto-
nia scale (n = 7), Activity of Daily Living scale (n = 5),
Gross Outcome Score (n = 5), Obeso scale (n = 1),
Toronto Western Spasmodic Torticollis Rating Scale
(n = 1), Tsui score (n = 1), and the Global Dystonia Rating
Scale (n = 1).
Motor Performance
BFMDRS scores were available for 53 of 100 (53%)
patients, showing improvement after pallidotomy in
51 of 53 patients (96%). Forty-two patients (79%)
showed improvement of 20% or more. In 34 patients
(64%) improvement was >40% at the end of reported
follow-up (Fig. 1). Improvement typically did not occur
in the early postoperative phase but became apparent
after several weeks to months (Fig. 2). Lin et al reported
a mean 13% improvement at 1-year follow-up in a
group of 18 patients with generalized dystonia
(no individual scores available).34 Cersosimo et al
reported on a patient with a maximum improvement of
76.2% at 3 months followed by a secondary
deterioration of 19% at 96 months.18 Another patient
experienced a temporary postoperative deterioration
for a few weeks but returned to preoperative level at
3 months.
Disability
A disability score was available for 21 patients
(21%). Fifteen patients showed an improvement
(14 patients >20%). Four patients showed no improve-
ment. The scores of 2 patients worsened, 1 of whom
had an initial improvement of 33% at 60 months that
dropped to –25% at 72 months. Lin et al also scored
the disability scale and reported a mean improvement
of 9% (no individual scores are available).34
In 17 other patients, the UDRS score was used. Of
those, the vast majority improved more than 20%
(n = 15; 88.2%), 1 patient improved 15%, and 1
patient improved 10%.40 On the remaining reported
scales, all patients improved (Table 1).
Sustainability
The mean follow-up was 18.2 months (range 2–
180 months; n = 83). In 17 patients, the follow-up
duration was not (individually) reported. In most
patients, the beneficial effect lasted through follow-up.
In 19 of 100 patients, a relapse of dystonic symptoms
was reported (Table 1). One study reported relapsing
SD.45 Six patients were treated with DBS after bilateral
pallidotomy, because their dystonic symptoms
reappeared after temporary benefit.24,38,49 The relapse
FIG. 2. Improvement BFMDRS (Burke-Fahn-Marsden Dystonia Rating Scale) movement score, categorized by percentage decrease in score at latest-
reported follow-up. Some studies report multiple follow-up moments. Letters a–c represent relapsing patients. For exact scores of patients see
Table 1. a: Hutchison et al (2003). 8.2% improvement immediately postoperatively and relapsed at 5-month follow-up to a level 14.3% worse than
baseline. b: Anca et al (2003), maximal improvement of 46.2% at 12-month follow-up, but the score had dropped to 33.3% improvement at 24-month
follow-up. c: Cersosimo et al (2008). Maximal improvement of 76.2% at 3-month follow-up and showed relapsing at 60-month follow-up. At 96-month
follow-up, the BFMDRS score had dropped to 19.1% worse than baseline. [Color figure can be viewed at wileyonlinelibrary.com]
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time of dystonic symptoms after pallidotomy varied
between 3 weeks and 4.5 years.
Safety
Adverse events were reported in 20 of 100 patients
(entire data set). Of note, adverse effects were some-
times reported in case series and therefore not analyzed
as adverse effects in individually reported patients. The
adverse effects in individually reported patients are
presented in Table 3. Twelve patients (60%) had a vari-
ety of transient side effects (lethargy, edema, subgaleal
effusion, urinary incontinence, visual field defects,
hemiparesis, unsteady gait, and fever). Eight patients
(40%) experienced permanent deficits (mutism,
hypophonia, dysphonia, anarthria, aphonia, dysarthria,
dysphagia, hyperhidrosis, and limitation of left horizon-
tal gaze). Surgical track hemorrhages were reported in
1 patient. In most cases (n = 19), adverse effects were
noticed shortly after surgery. One patient reported
development of aphonia at 1-year follow-up.17 No
deaths due to bilateral pallidotomy were registered.
Staged pallidotomy was reported in 12 of 48 patients
and simultaneous bilateral pallidotomy in 35 of
48 patients. For the remaining 52 cases, these data were
not reported. In the “staged” group, a case of unilateral
horizontal gaze impairment and a case of transient leth-
argy were reported. The other adverse events occurred
either in the “simultaneous” group or in the
“unreported” group.
One paper by Khandelwal et al was not included in
the overall analysis because of a lack of clinical out-
come data. Nevertheless, the paper is mentioned in
Table 3 because of a transient adverse effect of bilateral
mydriasis and visual field defects.50
Discussion
This systematic review evaluated the efficacy, safety,
and sustainability of bilateral pallidotomy for dystonia.
In 2008, Gross stated that improvement after pallidot-
omy was similar to DBS and that complications
appeared to be rare.51 Although this statement was
based on studies of unequal levels of scientific evidence,
it provides food for thought regarding whether the
abandonment of bilateral pallidotomy as a treatment
option in selected patients is justified. In the reviewed
papers, the rationale for choosing pallidotomy over
DBS is generally not mentioned. A few exceptions were
as follows: patients decided against implantation of
material inside their head, higher costs of DBS, and in
one case DBS was ineffective for SD and it was decided
to perform bilateral pallidotomy.
Efficacy and Sustainability
Bilateral pallidotomy was shown to lead to improve-
ment in the majority of patients with a reported
BFMDRS score (96%). BFMDRS score as the most rel-
evant outcome measure revealed an improvement of
20% or more in 42 of 53 patients (79%). Of these,
34 (64%) patients had an improvement of more than
40%. Three patients experienced secondary worsening
of the BFMDRS score, 2 of which returned to baseline
(Fig. 2).17,29 Although in some cases immediate effects
were reported, the beneficial effect of bilateral
TABLE 3. Reported adverse events in all studies mentioned in this review
Article Patients Permanent adverse events Transient adverse events
Khandelwal et al (2018) 1 Bilateral mydriasis and visual field defects
(n = 1)
Horisawa et al (2016) 1 Transient aggressive behavior (n = 1)
Fonoff et al (2012) 2 Severe hypophonia (n = 1), speech
impairment (n = 1)
Zirn et al (2011) 1 Mutism, dysarthria, dysphagia, and
hyperhidrosis (n = 1)
Cersosimo et al (2008) 1 Anarthria (n = 1)
Rakocevic et al (2004) 1 Left horizontal gaze preference (n = 1)
Eltahawy et al (2004) 2 Hypophonia (n = 1), dysphonia (n = 1)
Teive et al (2001) 2 Transient lethargy (n = 1), track
hemorrhages (n = 1)
Cubo et al (2000) 1 Right capsule edema (n = 1)
Ondo et al (1998) 1 Transient lethargy (n = 1)
Anca et al (2003) 1 Aphonia (n = 1)
Lin et al (1998)a 1 Transient right facial weakness (n = 1)
Lin et al (2001) 7 Urinary incontinence (n = 2), visual field
defects (n = 2), hemiparesis (n = 2),
unsteady gait (n = 1), fever (n = 1)
aAlso mentioned in Lin et al (2001).
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pallidotomy typically took weeks or months to occur.
The cause for heterogeneity in response time is
unknown. After bilateral pallidotomy, the disability
scale (maximal 30 points) showed overall a mean
improvement of 6.5 points (22%) but was observed
only in a minority of patients. Stewart and colleagues
concluded that the disability score is less responsive to
change in dystonic symptoms.52 There can be a mean-
ingful change in functioning in the absence of a disabil-
ity score improvement.53 All these aspects of
pallidotomy should be mentioned in counseling
patients.
No conclusions can be drawn concerning long-term
efficacy of bilateral pallidotomy in the treatment of dys-
tonia as the median-reported follow-up time was only
18 months.
In medication-refractory SD, bilateral pallidotomy
initially terminated in 23 of 25 reported cases (92%).
Remarkably, in a single study by Garone and col-
leagues after initial benefit, relapse of symptoms was
reported in 7 patients.45 Unfortunately, the (possible)
explanations for these relapses are not mentioned, nor
the duration of the relapse nor the type of dystonia. In
combination with the fact that this is the only study
that reports the recurrence of SD after bilateral pallidot-
omy, conclusions cannot be drawn on the risk of
relapse after SD. Of note, an additional search for
cases describing unilateral pallidotomy for SD was
performed, but such cases were not identified.
Safety
In the literature, adverse events of bilateral pallidot-
omy include hemiparesis, visual field defects, and neu-
ropsychological changes. The latter often disappear
within 6 months after pallidotomy but are reported per-
manent if lesions encroach the anteromedial (non-
motor) portion of the pallidum. Facial paresis is also
frequently reported. Limb paresis (up to 4%) and visual
field deficits (up to 14%) are less common. Of note,
most data on side effects of pallidotomy are from
patients with Parkinson’s disease.54
In this review, transient and permanent adverse
events were reported after bilateral pallidotomy. Tem-
porary lethargy and permanent speech disorders (eg,
hypophonia) were most frequently reported. Adverse
events were less reported after staged bilateral pallidot-
omy, but in 45 patients adverse events were not speci-
fied to be related to either a staged or a simultaneous
procedure, so these data should be interpreted with
caution. Also, some adverse events reported in a simul-
taneous procedure were the result of a unilateral com-
plication, for example, seizures by a hemorrhagic track.
Therefore, the safety benefits of staging the procedure
should be weighed carefully in individual cases. Based
on this review, the marginal safety gain of staging,
barely, if at all, outweighs the discomfort of two surger-
ies and the delayed relief of dystonic symptoms.
Five patients (5%) had permanent speech disorders
after bilateral pallidotomy. Transient or stimulation-
dependent speech disorders are also reported after
DBS.12 On the contrary, the same authors state that
DBS-hardware problems are very common (36.1%).
The adverse event profiles of both lesioning and DBS
are to be kept in mind when considering surgical treat-
ment, but as the profiles do not match, this should be
done with caution.
Finally, we identified 5 patients with DBS after bilat-
eral pallidotomy. DBS in both the internal globus
pallidus and subthalamic nucleus has been reported to
be successful. Although this is encouraging evidence,
we cannot draw conclusions from these data. The
reported cases in literature on this matter are scarce,
requiring further validation in future studies.
Limitations
The main limitation of this review is that only case
reports and case series on bilateral pallidotomy in dys-
tonia were available. This comes with a high probabil-
ity of underreporting of negative outcomes, leading to
inevitable publication bias in this review. The second
limitation of this study is that not all included patients
were evaluated using standardized assessment tools
(eg, BFMDRS, UDRS).
We recommend the application of standardized tools
such as BFMDRS for clinical assessment in future
reports on pallidotomy for dystonia. In addition, we
recommend the use of personalized goals.55,56 Finally,
the 12-month follow-up sample size was considerably
smaller than that at 3 and 6 months. As such, no defi-
nite conclusions can be drawn on long-term sustainabil-
ity of bilateral pallidotomy nor the risk of relapsing in
the long term. Data on specifics of surgical techniques
were too sparsely reported to consider in this analysis.
For future reports we suggest to provide at least the fol-
lowing points: general anesthesia or awake surgery, use
of micro-electrode recording, target localization, probe
type and diameter, lesioning duration and temperature,
and number of lesions per side and preferably postoper-
ative evaluation of lesion size and location.
The next step, a controlled trial of pallidotomy in
dystonia, is worth exploring, as this review shows not
only that pallidotomies in dystonia are currently being
performed and reported but also that there is at least
some equipoise in the field. The potential factors com-
plicating a controlled trial include the establishment of
DBS as the standard surgical treatment for dystonia in
most centers and the lack of proper neurosurgical train-
ing and expertise in ablative surgeries for movement
disorders.
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Conclusion
Based on this systematic literature review, bilateral
pallidotomy is in the short term an effective treatment
for dystonia, particularly in treating medication-
refractory SD and despite a considerable number of
adverse events. Given the burden of dystonia, bilateral
pallidotomy should be regarded a viable tool in the
armamentarium of the neurosurgeon in the treatment of
dystonia, particularly for patients with contraindications
for DBS or if the severity of the dystonic symptoms out-
weighs the risk of permanent speech disorders.
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